The Biology of Cystinuria: Genes and "COLA"
At a Glance
Cystinuria is caused by genetic mutations in the SLC3A1 or SLC7A9 genes that stop the kidneys from recycling the "COLA" amino acids. This causes cystine to build up in the urine and form stones. While there are different genetic types (A, B, or AB), the core treatment plan remains the same.
To understand cystinuria, it helps to think of your kidneys as a highly efficient recycling center. Normally, when your blood is filtered, the kidneys identify valuable nutrients and “recycle” them back into your bloodstream. In cystinuria, a “glitch” in the recycling machinery causes the body to lose these nutrients in the urine instead [1][2].
The COLA Amino Acids
The “glitch” affects a specific group of four amino acids, often remembered by the acronym COLA:
- Cystine
- Ornithine
- Lysine
- Arginine
While all four of these amino acids are lost in the urine, only cystine causes problems [1]. This is because ornithine, lysine, and arginine dissolve very easily in liquid. Cystine, however, is like sand in a glass of water—it does not dissolve well [1]. When cystine levels in the urine become too high, the “sand” settles and forms sharp, hard crystals that eventually grow into kidney stones [3][2].
The Recycling Machinery: rBAT and b0,+AT
The recycling process is carried out by a specialized “transporter” complex in the proximal tubule (the first part of the kidney’s filtering system) [2][4]. This transporter is made of two proteins that work together like a lock and a key:
- rBAT (The “Heavy Chain”): Encoded by the SLC3A1 gene [4][5].
- b0,+AT (The “Light Chain”): Encoded by the SLC7A9 gene [4][5].
If either part of this “recycling machine” is broken due to a genetic mutation, the machine cannot pick up the COLA amino acids, and they are flushed out into the urine [2].
Understanding Your Type: A, B, and AB
Cystinuria is classified into types based on which “part” of the machine is broken:
- Type A (SLC3A1 mutations): This is the most classic form and follows an autosomal recessive inheritance pattern [5]. This means a person must inherit one broken copy of the gene from each parent to have the disease. Parents are typically “carriers” who have no symptoms and normal urine [5].
- Type B (SLC7A9 mutations): This type is slightly more complex. While it is also recessive, some “carriers” (who have only one broken copy) might actually leak a small amount of cystine into their urine, a pattern called incomplete dominance [5][2].
- Type AB (Digenic): This is a rarer form where a person has one mutation in the SLC3A1 gene and another in the SLC7A9 gene [6][7].
Does the Subtype Change the Symptoms?
For most people, the “type” does not change the daily reality of the disease. However, researchers have noticed a few subtle patterns:
- Earlier Onset: Some studies suggest that patients with Type B or AB mutations might start forming stones at an earlier age compared to those with Type A [8][9].
- Bilateral Stones: There is some evidence that Type B patients may be more likely to develop stones in both kidneys (bilateral) rather than just one [10].
Despite these small differences, there is a “poor genotype-phenotype correlation” in cystinuria [11][8]. This means that knowing your genetic type cannot perfectly predict how many stones you will have or how severe they will be. Because the “end result” is always excess cystine in the urine, the treatment remains consistent regardless of the genetic subtype: drink plenty of fluids, manage urine pH, and monitor for stones [9][12][13].
Common questions in this guide
What are the COLA amino acids in cystinuria?
What is the difference between Type A and Type B cystinuria?
Does my cystinuria genetic type change how the condition is treated?
Should my family members be tested for cystinuria?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on our genetic testing, do I/my child have Type A, Type B, or Type AB cystinuria?
- 2.Since I/my child carry this mutation, what is the risk that my other children or future children will have the condition?
- 3.Does the specific mutation identified change how frequently we should be screening for new stones?
- 4.Should other family members (like my parents or siblings) have their urine tested for cystine levels, even if they don't have stones?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
Cystinuria in Dogs and Cats: What Do We Know after Almost 200 Years?
Kovaříková S, Maršálek P, Vrbová K
Animals : an open access journal from MDPI 2021; (11(8)) doi:10.3390/ani11082437.
PMID: 34438894 - 2
Clinical and molecular characterization of cystinuria in a French cohort: relevance of assessing large-scale rearrangements and splicing variants.
Gaildrat P, Lebbah S, Tebani A, et al.
Molecular genetics & genomic medicine 2017; (5(4)):373-389 doi:10.1002/mgg3.294.
PMID: 28717662 - 3
Genetic defects underlying renal stone disease.
Rumsby G
International journal of surgery (London, England) 2016; (36(Pt D)):590-595 doi:10.1016/j.ijsu.2016.11.015.
PMID: 27838384 - 4
Structural basis for amino acid exchange by a human heteromeric amino acid transporter.
Wu D, Grund TN, Welsch S, et al.
Proceedings of the National Academy of Sciences of the United States of America 2020; (117(35)):21281-21287 doi:10.1073/pnas.2008111117.
PMID: 32817565 - 5
Analysis of SLC7A9 gene mutations among Jordanian patients with cystinuria.
Halalsheh OM, Al-Shehabat MA, Al-Ghazo MA, et al.
Annals of medicine and surgery (2012) 2021; (63()):102182 doi:10.1016/j.amsu.2021.102182.
PMID: 33680451 - 6
Digenic Inheritance in Cystinuria Mouse Model.
Espino M, Font-Llitjós M, Vilches C, et al.
PloS one 2015; (10(9)):e0137277 doi:10.1371/journal.pone.0137277.
PMID: 26359869 - 7
A Case of Cystinuria With Compound Heterozygous Mutations Both in SLC3A1 and SLC7A9 Genes.
Suh SH, Song SH, Choi HS, et al.
Electrolyte & blood pressure : E & BP 2025; (23(1)):17-21 doi:10.5049/EBP.2025.23.e2.
PMID: 40630605 - 8
Genotype and Phenotype Analysis in Pediatric Patients with Cystinuria.
Kim JH, Park E, Hyun HS, et al.
Journal of Korean medical science 2017; (32(2)):310-314 doi:10.3346/jkms.2017.32.2.310.
PMID: 28049243 - 9
Clinical profile of a Polish cohort of children and young adults with cystinuria.
Tkaczyk M, Gadomska-Prokop K, Załuska-Leśniewska I, et al.
Renal failure 2021; (43(1)):62-70 doi:10.1080/0886022X.2020.1860089.
PMID: 33349102 - 10
Genetic and clinical analysis of Chinese pediatric patients with cystinuria.
Zhan R, Ge Y, Liu Y, et al.
Urolithiasis 2022; (51(1)):20 doi:10.1007/s00240-022-01398-z.
PMID: 36571637 - 11
Delineation of cystinuria in Saudi Arabia: A case series.
Obaid A, Nashabat M, Al Fakeeh K, et al.
BMC nephrology 2017; (18(1)):50 doi:10.1186/s12882-017-0469-x.
PMID: 28166740 - 12
Case-based review of dietary management of cystinuria.
Ucmak H, Sonmez MG, Guven S
World journal of urology 2023; (41(5)):1215-1220 doi:10.1007/s00345-022-04263-1.
PMID: 36565321 - 13
Update on cystine stones: current and future concepts in treatment.
Moussa M, Papatsoris AG, Abou Chakra M, Moussa Y
Intractable & rare diseases research 2020; (9(2)):71-78 doi:10.5582/irdr.2020.03006.
PMID: 32494553
This page explains the biology and genetics of cystinuria for educational purposes. Always consult a genetic counselor or your healthcare provider to understand your specific genetic test results and family risks.
Get notified when new evidence is published on Cystinuria.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.